SKC UK CEO and Chair of Trustees meet with Batley and Spen MP Kim Leadbeater
This week Gail Jackson and Nick Bird were invited to speak with MP for Batley and Spen Kim Leadbeater in Westminster following her recent support for driving more research into childhood cancers including neuroblastoma.
Research update- March 2022
In 2022 we are aiming to improve and increase patient representation in neuroblastoma research. This spotlight on research advocacy explains exactly what that means and how we will achieve it.
Solving Kids' Cancer UK Named Funds
We’re thrilled to be launching our Solving Kids’ Cancer UK Named Funds, a unique way to raise funds in your child’s name and help make a difference for all children and families affected by neuroblastoma both now and in the future.
Relapse prevention therapies: an in-depth look
In this special edition of our research blog, Research Director and Chair of Trustees, Nick Bird, looks at the landscape of maintenance therapies and their accessibility in the UK.
Neuroblastoma Parent Global Symposium 2021- A round-up
Read the highlights of our second virtual parent conference hosted with Solving Kids' Cancer Us and the Children's Neuroblastoma Cancer Foundation.
Research update- December 2021
Heading into Winter, we have lots of exciting updates from the Research team at Solving Kids' Cancer.
Chair of Trustees lead author on landmark advocate-only paper published in the Journal of Clinical Oncology
A major achievement as the first ever manuscript authored by patient advocates working in the field of childhood cancer was published in the Journal of Clinical Oncology.
Solving Kids' Cancer meets Google
CEO, Gail Jackson, reflects on our recent strategy meeting with volunteers from Google.
Carl Cavers CEO of Sumo Group joins Solving Kids' Cancer UK as New Charity Patron
We are delighted to announce Carl Cavers, CEO of Sumo Group, has joined Solving Kids’ Cancer UK as our new Patron.
